BTK and glioblastoma: In GBM, approximately 25% of DAPI-positive cells did not express BTK or SOX2, 15% expressed BTK but not SOX2, 48% expressed SOX2 but not BTK, and 12% expressed both BTK and SOX2 (Fig 10A–F).